ELI LILLY & Co
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Immunology — Worldwide revenue [legacy total] by Year
Immunology — Worldwide revenue ($M) [legacy total] ($M)
Eli Lilly Immunology — Worldwide revenue [legacy total]: $605M in FY2017, up 435.0% from a year earlier. No newer figure appears in the documents we track.
Where the FY2017 figure comes from
Source: Form 10-K (filed 2018-02-20) ↗
Reported in Form 10-Q / 10-K Note 2.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Immunology — Worldwide revenue ($M) [legacy total] ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2017 | Dec 31, 2017 | 605 | +435.0% | Form 10-K (filed 2018-02-20) ↗ |
| FY2016 | Dec 31, 2016 | 113 | – | Form 10-K (filed 2018-02-20) ↗ |
Cite this data
StockData. (2026). Eli Lilly Immunology — Worldwide revenue [legacy total] ($M), annual FY2016–FY2017 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/ta-immunology-ww-legacy
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.